Literature DB >> 8995106

Pharmacology of cancer chemotherapy in the older person.

S D Baker1, L B Grochow.   

Abstract

With more widespread use of effective chemotherapy, more elderly patients are candidates for treatment with cytotoxic drugs. This article reviews and discusses the relevant age-related factors that may alter drug disposition and its relationship to pharmacokinetics effects and to pharmacodynamic effects in the elderly.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 8995106

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN： 0749-0690            Impact factor:   3.076


  18 in total

Review 1.  Pharmacology of anticancer drugs in the elderly population.

Authors:  Hans Wildiers; Martin S Highley; Ernst A de Bruijn; Allan T van Oosterom
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  [Comorbidity oriented oncology - an overview].

Authors:  Ralph Simanek; Michael Wuensch; Roland Edlinger; Bernhard Hammerl-Ferrari; Ludwig Kramer; Klaus Geissler
Journal:  Wien Klin Wochenschr       Date:  2010-04       Impact factor: 1.704

3.  Short-term monitoring of cognitive functions before and during the first course of treatment.

Authors:  Barbara Eberhardt; Stefan Dilger; Frauke Musial; Ulrich Wedding; Thomas Weiss; Wolfgang H R Miltner
Journal:  J Cancer Res Clin Oncol       Date:  2006-01-14       Impact factor: 4.553

Review 4.  Systemic therapies for metastatic renal cell carcinoma in older adults.

Authors:  Sumanta K Pal; Ari Vanderwalde; Arti Hurria; Robert A Figlin
Journal:  Drugs Aging       Date:  2011-08-01       Impact factor: 3.923

Review 5.  Effect of age on drug metabolism in women with breast cancer.

Authors:  Jasmeet C Singh; Stuart M Lichtman
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-05       Impact factor: 4.481

6.  Management of Elderly Patients with Plasma Cell Myeloma.

Authors:  Erica L Campagnaro; Teresa E Goebel; Hillard M Lazarus
Journal:  Drugs Aging       Date:  2015-06       Impact factor: 3.923

Review 7.  Pharmacokinetic considerations of oral chemotherapy in elderly patients with cancer.

Authors:  J Andrew Skirvin; Stuart M Lichtman
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

8.  Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials.

Authors:  Sara Bringhen; Maria Victoria Mateos; Sonja Zweegman; Alessandra Larocca; Antonietta Pia Falcone; Albert Oriol; Davide Rossi; Maide Cavalli; Pierre Wijermans; Roberto Ria; Massimo Offidani; Juan Jose Lahuerta; Anna Marina Liberati; Roberto Mina; Vincenzo Callea; Martijn Schaafsma; Chiara Cerrato; Roberto Marasca; Luca Franceschini; Andrea Evangelista; Ana-Isabel Teruel; Bronno van der Holt; Vittorio Montefusco; Giovannino Ciccone; Mario Boccadoro; Jesus San Miguel; Pieter Sonneveld; Antonio Palumbo
Journal:  Haematologica       Date:  2013-02-26       Impact factor: 9.941

Review 9.  Practical treatment guide for dose individualisation in cancer chemotherapy.

Authors:  P Canal; E Chatelut; S Guichard
Journal:  Drugs       Date:  1998-12       Impact factor: 9.546

Review 10.  The Evolving Complexity of Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer: Special Considerations in Older Breast Cancer Patients-Part II: Metastatic Disease.

Authors:  Addie Hill; Eutiquio Gutierrez; Jennifer Liu; Sarah Sammons; Gretchen Kimmick; Mina S Sedrak
Journal:  Drugs Aging       Date:  2020-05       Impact factor: 3.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.